Mary Wilhelm

Mary Wilhelm is an accomplished professional in regulatory affairs with extensive experience in the life sciences sector. Currently serving as a Guest Lecturer at the University of Southern California and as Senior Director of Regulatory Affairs at Ascendis Pharma, Mary has previously held key positions including Executive Director of Regulatory Affairs at Intercept Pharmaceuticals and Senior Director of Regulatory Affairs at Halozyme Therapeutics, Inc. With a solid academic foundation, Mary earned a Doctor of Science in Regulatory Sciences from the University of Southern California and holds multiple master's and bachelor's degrees from Purdue University and San Diego State University. Mary's expertise encompasses regulatory strategy, compliance, and leadership in partnerships across various sectors of the industry.